sars

sars

New Targets for SARS/MERS Drugs

1w ago
SOURCE  

Description

Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing an expanding epidemic of a “SARS-like” illness in the Middle East with exported cases to the United States, Europe, Asia, and Africa. Reports of human-to-human transmission of MERS-CoV in healthcare facilities and close family contacts have raised global concern about its pandemic potential. Unfortunately there are currently no antiviral agents approved for treatment of MERS or SARS. Researchers will discuss late-breaking research on a newly identified candidate compound as well as other options for treatment currently in the pipeline. Hao Lei, University of Illinois at Chicago Hyun Lee, University of Illinois at Chicago Jasper Chan, University of Hong Kong